{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:55:32Z","timestamp":1790988932911,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Adrenomed AG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00134-021-06537-5","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T20:07:40Z","timestamp":1633378060000},"page":"1284-1294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial"],"prefix":"10.1007","volume":"47","clinical-trial-number":[{"clinical-trial-number":"nct03085758","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Pierre-Fran\u00e7ois","family":"Laterre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pickkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Wittebole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhat","family":"Meziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Dugernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Huberlant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schuerholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Lascarrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albertus","family":"Beishuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haikel","family":"Oueslati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Contou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Hoiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Lacherade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Chousterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Pottecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Godet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahir","family":"Karakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Pars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8715-7753","authenticated-orcid":false,"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the AdrenOSS-2 study participants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Castanares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Collienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"G\u00e8rards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillipe","family":"Hantson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Montiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Berghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Gielens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Jorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Asfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtan","family":"Plantef\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Duranteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Vuillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Fedou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Goudelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Daix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Desachy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Aurore","family":"Duchambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Baudrillart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bourzeix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Prevost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Chalot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Herafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Engels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ma\u00eblle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila-Fariza","family":"Abeud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Berton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamile","family":"Cerlinskaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Deye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Celine","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassadit","family":"Hadjam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Hollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuija","family":"Javanainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Jourdaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badr","family":"Louadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Neuschwander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Clere-Jehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Demiselle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Merdji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Monnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur R. H.","family":"van Zanten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wytze","family":"Vermeijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Dormans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,4]]},"reference":[{"issue":"8","key":"6537_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801\u2013810","journal-title":"JAMA"},{"issue":"7","key":"6537_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMcibr1007320","volume":"363","author":"WL Lee","year":"2010","unstructured":"Lee WL, Slutsky AS (2010) Sepsis and endothelial permeability. N Engl J Med 363(7):689\u2013691","journal-title":"N Engl J Med"},{"issue":"4","key":"6537_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2174\/157340211799304761","volume":"7","author":"NO Karpinich","year":"2011","unstructured":"Karpinich NO, Hoopes SL, Kechele DO, Lenhart PM, Caron KM (2011) Adrenomedullin function in vascular endothelial cells: insights from genetic mouse models. Curr Hypertens Rev 7(4):228\u2013239","journal-title":"Curr Hypertens Rev"},{"issue":"1","key":"6537_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/hy1201.097201","volume":"39","author":"KH Hofbauer","year":"2002","unstructured":"Hofbauer KH, Schoof E, Kurtz A, Sandner P (2002) Inflammatory cytokines stimulate adrenomedullin expression through nitric oxide-dependent and -independent pathways. Hypertension 39(1):161\u2013167","journal-title":"Hypertension"},{"issue":"2","key":"6537_CR5","doi-asserted-by":"publisher","first-page":"R513","DOI":"10.1152\/ajpregu.2000.278.2.R513","volume":"278","author":"KH Hofbauer","year":"2000","unstructured":"Hofbauer KH, Jensen BL, Kurtz A, Sandner P (2000) Tissue hypoxygenation activates the adrenomedullin system in vivo. Am J Physiol Regul Integr Comp Physiol 278(2):R513-519","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"6537_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1006\/bbrc.1995.2497","volume":"215","author":"H Shoji","year":"1995","unstructured":"Shoji H, Minamino N, Kangawa K, Matsuo H (1995) Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat. Biochem Biophys Res Commun 215(2):531\u2013537","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"6537_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s13054-018-2243-2","volume":"22","author":"A Mebazaa","year":"2018","unstructured":"Mebazaa A, Geven C, Hollinger A, Wittebole X, Chousterman BG, Blet A, Gayat E, Hartmann O, Scigalla P, Struck J et al (2018) Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational adrenomedullin and outcome in sepsis and septic shock-1 (AdrenOSS-1) study. Crit Care 22(1):354","journal-title":"Crit Care"},{"issue":"2","key":"6537_CR8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.chest.2017.03.035","volume":"152","author":"P Caironi","year":"2017","unstructured":"Caironi P, Latini R, Struck J, Hartmann O, Bergmann A, Maggio G, Cavana M, Tognoni G, Pesenti A, Gattinoni L et al (2017) Circulating biologically active adrenomedullin (bio-ADM) predicts hemodynamic support requirement and mortality during sepsis. Chest 152(2):312\u2013320","journal-title":"Chest"},{"issue":"5","key":"6537_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3343\/alm.2019.39.5.454","volume":"39","author":"H Kim","year":"2019","unstructured":"Kim H, Hur M, Struck J, Bergmann A, Di Somma S (2019) Circulating biologically active adrenomedullin predicts organ failure and mortality in sepsis. Ann Lab Med 39(5):454\u2013463","journal-title":"Ann Lab Med"},{"issue":"2","key":"6537_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/SHK.0000000000001103","volume":"50","author":"C Geven","year":"2018","unstructured":"Geven C, Bergmann A, Kox M, Pickkers P (2018) Vascular Effects of adrenomedullin and the anti-adrenomedullin antibody adrecizumab in sepsis. Shock 50(2):132\u2013140","journal-title":"Shock"},{"issue":"6","key":"6537_CR11","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/SHK.0000000000001102","volume":"50","author":"C Geven","year":"2018","unstructured":"Geven C, Peters E, Schroedter M, Struck J, Bergmann A, McCook O, Radermacher P, Kox M, Pickkers P (2018) Effects of the humanized anti-adrenomedullin antibody adrecizumab (HAM8101) on vascular barrier function and survival in rodent models of systemic inflammation and sepsis. Shock 50(6):648\u2013654","journal-title":"Shock"},{"issue":"1","key":"6537_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40635-019-0255-0","volume":"7","author":"A Blet","year":"2019","unstructured":"Blet A, Deniau B, Geven C, Sadoune M, Caillard A, Kounde PR, Polidano E, Pickkers P, Samuel JL, Mebazaa A (2019) Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats. Intensive Care Med Exp 7(1):25","journal-title":"Intensive Care Med Exp"},{"issue":"1","key":"6537_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2197-425X-1-2","volume":"1","author":"K Wagner","year":"2013","unstructured":"Wagner K, Wachter U, Vogt JA, Scheuerle A, McCook O, Weber S, Groger M, Stahl B, Georgieff M, Moller P et al (2013) Adrenomedullin binding improves catecholamine responsiveness and kidney function in resuscitated murine septic shock. Intensive Care Med Exp 1(1):21","journal-title":"Intensive Care Med Exp"},{"issue":"6","key":"6537_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/SHK.0000000000001587","volume":"54","author":"C Thiele","year":"2020","unstructured":"Thiele C, Simon TP, Szymanski J, Daniel C, Golias C, Hartmann O, Struck J, Martin L, Marx G, Schuerholz T (2020) Effects of the non-neutralizing humanized monoclonal anti-adrenomedullin antibody adrecizumab on hemodynamic and renal injury in a porcine two-hit model. Shock 54(6):810\u2013818","journal-title":"Shock"},{"issue":"21","key":"6537_CR15","first-page":"2063","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369(21):2063","journal-title":"N Engl J Med"},{"issue":"5","key":"6537_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s00134-020-05934-6","volume":"46","author":"MO Harhay","year":"2020","unstructured":"Harhay MO, Casey JD, Clement M, Collins SP, Gayat \u00c9, Gong MN, Jaber S, Laterre PF, Marshall JC, Matthay MA et al (2020) Contemporary strategies to improve clinical trial design for critical care research: insights from the first critical care clinical Trialists workshop. Intensive Care Med 46(5):930\u2013942","journal-title":"Intensive Care Med"},{"key":"6537_CR17","doi-asserted-by":"crossref","unstructured":"Geven C, Blet A, Kox M, Hartmann O, Scigalla P, Zimmermann J, Marx G, Laterre PF, Mebazaa A, Pickkers P (2019) A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2). BMJ Open 0:e024475","DOI":"10.1136\/bmjopen-2018-024475"},{"issue":"1","key":"6537_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13054-017-1609-1","volume":"21","author":"HJ de Grooth","year":"2017","unstructured":"de Grooth HJ, Geenen IL, Girbes AR, Vincent JL, Parienti JJ, Oudemans-van Straaten HM (2017) SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care 21(1):38","journal-title":"Crit Care"},{"issue":"9","key":"6537_CR19","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1111\/bcp.13655","volume":"84","author":"C Geven","year":"2018","unstructured":"Geven C, van Lier D, Blet A, Peelen R, Ten Elzen B, Mebazaa A, Kox M, Pickkers P (2018) Safety, tolerability and pharmacokinetics\/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects. Br J Clin Pharmacol 84(9):2129\u20132141","journal-title":"Br J Clin Pharmacol"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-021-06537-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-021-06537-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-021-06537-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T19:08:37Z","timestamp":1744139317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-021-06537-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,4]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["6537"],"URL":"https:\/\/doi.org\/10.1007\/s00134-021-06537-5","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,4]]},"assertion":[{"value":"12 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"P-F L received fees as a coordinator of the CCC. PP reports travel and consultancy reimbursement from Adrenomed, SphingoTec, 4TEEN4, AM-Pharma, Baxter, EBI. XW was part of the Clinical Coordinating Center assessing patient\u2019s eligibility. No other conflict of interest. FM has no conflict of interest. TD received fees as a coordinator of the CCC. BF reports personal fees outside the submitted work from Inotrem, Biom\u00e9rieux, AM-Pharma, Takeda, Enlivex, Aridis, GSK, Asahi-Kasai. JBL reported receiving consultation fees from Asahi Kasei America Corporation outside the submitted work. AB Consultancy fees from GSK and Danone Nutricia. DC has no conflict of interest. OH has no conflict of interest. JCL has no conflict of interest to declare. BC served as a member of an advisory board for Roche Diagnostics. JP has no conflict of interest with the present work. MB holds shares of SmartDyeLivery GmbH, Jena. He has received funding for scientific advisory boards, travel and speaker honoraria by T2 Biosystems, Inc., La Jolla Pharmaceutical Company, SNIPR BIOME Denmark, CytoSorbents GmbH, Thermo Fisher Scientific (B\u00b7R\u00b7A\u00b7H\u00b7M\u00b7S GmbH), Roche Diagnostics International Ltd., Transgene S.A. and SphingoTec GmbH. TG has non conflict of interest with the present work. MK reports grant support from Adrenomed and Vifor, and honoraria from Adrenomed, SphingoTec, Vifor, Amgen, 4TEEN4, Astra-Zeneca, and Sanofi. AM reports personal fees from Orion, Sanofi, Adrenomed, Epygon and Fire 1 and grants and personal fees from 4TEEN4, Abbott, Roche and SphingoTec.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}